s and consent to participate {#FPar0} =================================  The study was approved by the University of Nebraska Medical Center IRB Committee (Protocol 000-00-EX) and the Gharbiah Cancer Society IRB Committee in Egypt. No patients were approached for this study and the secondary analysis of data of the medical records did not include any data of children. The consent was waived by the IRB Committees listed above in Egypt and Nebraska because of the secondary analysis of the aggregate data of the study.  